Coxibs: Is there a benefit when compared to traditional non-selective NSAIDs in postoperative pain management?

Minerva Anestesiologica

Volumn 77, Issue 11, 2011, Pages 1084-1098

  Wickerts, L ^a   Warren Stomberg M ^b   Brattwall, M ^b   Jakobsson, J ^c  

^a DANDERYD HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Ambulatory surgical procedures; Analgesia; Anti inflammatory agents; Cyclooxygenase 2 inhibitors; Non steroidal; Pain; Postoperative

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CODEINE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; ETORICOXIB; HYDROCODONE BITARTRATE PLUS PARACETAMOL; IBUPROFEN; KETOPROFEN; KETOROLAC; LUMIRACOXIB; MORPHINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PARACETAMOL; PARECOXIB; PIROXICAM; PLACEBO; PROSTACYCLIN; ROFECOXIB; TRAMADOL; VALDECOXIB;

ANALGESIC ACTIVITY; BEDTIME DOSAGE; BLEEDING; BONE DEFECT; CARDIOVASCULAR RISK; COLLES FRACTURE; COMPARATIVE EFFECTIVENESS; CONTINUOUS INFUSION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INHIBITION; DRUG INTERMITTENT THERAPY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; FRACTURE; FRACTURE HEALING; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HEART DEATH; HEART INFARCTION; HUMAN; LOADING DRUG DOSE; NONHUMAN; ORTHOPEDIC SURGERY; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE PAIN; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; STOMACH IRRITATION; STROKE; THROMBOCYTE FUNCTION; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME; ULCER; WOUND INFECTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; BLOOD PLATELETS; BONE AND BONES; CARDIOVASCULAR DISEASES; CYCLOOXYGENASE 2 INHIBITORS; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; FRACTURES, BONE; GASTROINTESTINAL DISEASES; HUMANS; ORTHOPEDIC PROCEDURES; PAIN MANAGEMENT; PAIN, POSTOPERATIVE; POSTOPERATIVE HEMORRHAGE; SURGICAL PROCEDURES, MINOR; THROMBOEMBOLISM;

EID: 80355128169     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Derry C, Derry S, Moore RA, McQuay HJ. Single dose oral ibuprofen for acute postoperative pain in adults. Cochrane Database Syst Rev 2009;3:CD001548.
2. Derry S, Barden J, McQuay HJ, Moore RA. Single dose oral celecoxib for acute postoperative pain in adults. Cochrane Database Syst Rev 2008;4:CD004233.
3. Bandolier,Evidence Based Thinking About Healthcare [Homepage]. [cited May 4, 2011]. Available at:http://www.medicine.ox.ac.uk/bandolier/booth/painpag/Acutrev/Anal-gesics/Leagtab.html
4. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-infammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000;284:1247-55.
5. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000;343: 520-8.
6. Chan FK, Lanas A, Scheiman J, Berger MF, Nguyen H, Goldstein JL. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet 2010;376:173-9.
7. Latimer N, Lord J, Grant RL, O'Mahony R, Dickson J, Conaghan PG; National Institute for Health and Clinical Excellence Osteoarthritis Guideline Development Group. Cost efectiveness of COx 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis. BMJ 2009;339:b2538. doi: 10.1136/bmj.b2538
8. Hashash JG, Atweh LA, Saliba T, Chakhachiro Z, Al-Kutoubi A, Tawil A et al. Acute NSAID-related transmural duodenitis and extensive duodenal ulceration. Clin Ter 2007;29:2448-52.
9. Goldstein JL, Aisenberg J, Lanza F, Schwartz H, Sands GH, Berger MF et al. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years. Clin Ter 2006;28:340-51.
10. Jones P, Lamdin R. Oral cyclo-oxygenase 2 inhibitors versus other oral analgesics for acute soft tissue injury: systematic review and meta-analysis. Clin Drug Investig 2010;30:419-37.
11. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COx-2 inhibitors. JAMA 2001;286:954-9.
12. Jaksch W, Dejaco C, Schirmer M. 4 years after withdrawal of rofecoxib: where do we stand today? Rheumatol Int 2008;28:1187-95.
13. U.S. Food and Drug Administration. Analysis and recommendations for agency action regarding nonsteroidal antiinfammatory drugs and cardiovascular risk. J Pain Palliat Care Pharmacother 2005;19:83-97.
14. Friedewald VE, Bennett JS, Christo JP, Pool JL, Scheiman JM, Simon LS et al. AJC Editors consensus: Selective and nonselective nonsteroidal anti-inf' ammatory drugs and cardiovascular risk. Am J Cardiol 2010;106:873-84.
15. EMEA - European Medicines Agency [Homepage]. [cited May 4, 2011]. Available at:http://www.ema.europa. eu/docs/en_GB/document_library/Report/2010/01/ WC500054344.pdf
16. Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschan-nen B, Villiger PM et al. Cardiovascular safety of nonsteroidal anti-infammatory drugs: network meta-analysis. BMJ 2011;342:c7086. doi: 10.1136/bmj.c7086.
17. Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL et al. Complications of the COx-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N EnglJ Med 2005;352:1081-91.
18. Nussmeier NA, Whelton AA, Brown MT, Joshi GP, Lang-ford RM, Singla NK et al. Safety and ef cacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery. Anesthesiology 2006;104:518-26.
19. Langford RM, Joshi GP, Gan TJ, Mattera MS, Chen WH, Revicki DA et al. Reduction in opioid-related adverse events and improvement in function with parecoxib followed by valdecoxib treatment after non-cardiac surgery: a randomized, double-blind, placebo-controlled, parallel-group trial. Clin Drug Investig 2009;29:577-90.
20. Schug SA, Joshi GP, Camu F, Pan S, Cheung R. Cardiovascular safety of the cyclooxygenase-2 selective inhibitors parecoxib and valdecoxib in the postoperative setting: an analysis of integrated data. Anesth Analg 2009;108:299-307.
21. Leonelli SM, Goldberg BA, Safanda J, Bagwe MR, Sethu-ratnam S, King SJ. Efects of a cyclooxygenase-2 inhibitor (rofecoxib) on bone healing. Am J Orthop (Belle Mead NJ) 2006;35:79-84.
22. O'Connor JP, Capo JT, Tan V, Cottrell JA, Manigrasso MB, Bontempo N et al. A comparison of the ef ects of ibuprofen and rofecoxib on rabbit fbula osteotomy healing. Acta Orthop 2009;80:597-605.
23. Gerstenfeld LC, Tiede M, Seibert K, Mielke C, Phippard D, Svagr B et al. Diferential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-infammatory drugs. J Orthop Res 2003;21:670-5.
24. Gerstenfeld LC, Al-Ghawas M, Alkhiary YM, Cullinane DM, Krall EA, Fitch JL et al. Selective and nonselective yclooxygenase-2 inhibitors and experimental fracture-healing. Reversibility of efects after short-term treatment. Bone Joint Surg Am 2007;89:114-25.
25. Matsumoto MA, De Oliveira A, Ribeiro Junior PD, Nary Filho H, Ribeiro DA. Short-term administration of non-selective and selective COx-2 NSAIDs do not interfere with bone repair in rats. J Mol Histol 2008;39:381-7.
26. Tiseo BC, Namur GN, de Paula EJ, Junior RM, de Oliveira CR. Experimental study of the action of COx-2 selective nonsteroidal anti-inf ammatory drugs and traditional anti-infammatory drugs in bone regeneration. Clinics (Sao Paulo) 2006;61:223-30.
27. Utvåg SE, Fuskevåg OM, Shegarf H, Reikerås O. Short-term treatment with COx-2 inhibitors does not impair fracture healing. J Invest Surg 2010;23:257-61.
28. Fracon RN, Teolo JM, Moris IC, Lamano T Treatment with paracetamol, ketorolac or etoricoxib did not hinder alveolar bone healing: a histometric study in rats. J Appl Oral Sci 2010;18:630-4.
29. Adolphson P, Abbaszadegan H, Jonsson U, Dalén N, Sjöberg HE, Kalén S. No efects of piroxicam on osteopenia and recovery after Colles' fracture. A randomized, double-blind, placebo-controlled, prospective trial. Arch Orthop Trauma Surg 1993;112:127-30.
30. Kay RM, Directo MP, Leathers M, Myung K, Skaggs DL. Complications of ketorolac use in children undergoing operative fracture care. J Pediatr Orthop 2010;30:655-8.
31. Glassman SD, Rose SM, Dimar JR, Puno RM, Campbell MJ, Johnson JR. Te effect of postoperative nonsteroidal anti-infammatory drug administration on spinal fusion. Spine (Phila Pa 1976) 1998;23:834-8.
32. Park SY, Moon SH, Park MS, Oh KS, Lee HM. Te effects of ketorolac injected via patient controlled analgesia postoperatively on spinal fusion. Yonsei Med J 2005;46:245-51.
33. Reuben SS, Ablett D, Kaye R. High dose nonsteroidal anti-inf ammatory drugs compromise spinal fusion. Can J Anaesth 2005;52:506-12.
34. Lumawig JM, Yamazaki A, Watanabe K. Dose-dependent inhibition of diclofenac sodium on posterior lumbar interbody fusion rates. Spine J 2009;9:343-9.
35. Seidenberg AB, An YH. Is there an inhibitory efect of COx-2 inhibitors on bone healing? Pharmacol Res 2004;50:151-6.
36. Li Q, Zhang Z, Cai Z. High-dose ketorolac afects adult spinal fusion: a meta-analysis of the efect of perioperative nonsteroidal anti-infammatory drugs on spinal fusion. Spine (Phila Pa 1976) 2010 [Epub ahead of print].
37. Dodwell ER, Latorre JG, Parisini E, Zwettler E, Chandra D, Mulpuri K et al. NSAID exposure and risk of nonunion: a meta-analysis of case-control and cohort studies. Calcif Tissue Int 2010;87:193-202.
38. Bandolier. SAIDs, coxibs, smoking, and bone [Internet]. [cited May 4, 2011]. Available at:http://www.medicine. ox.ac.uk/bandolier/booth/painpag/wisdom/NSAIbone. html
39. Fischer HB, Simanski CJ. A procedure-specifc systematic review and consensus recommendations for analgesia after total hip replacement. Anaesthesia 2005;60:1189-202.
40. Fischer HB, Simanski CJ, Sharp C, Bonnet F, Camu F, Neugebauer EA et al; PROSPECT Working Group. A procedure-specif c systematic review and consensus recommendations for postoperative analgesia following total knee arthroplasty. Anaesthesia 2008;63:1105-23.
41. Meunier A, Aspenberg P, Good L. Celecoxib does not appear to afect prosthesis f xation in total knee replacement: A randomized study using radiostereometry in 50 patients. Acta Orthop 2009;80:46-50.
42. O'Connor JP, Lysz T Celecoxib, NSAIDs and the skeleton. Drugs Today (Barc) 2008;44:693-709.
43. Duellman TJ, Gafgan C, Milbrandt JC, Allan DG. Multimodal, pre-emptive analgesia decreases the length of hospital stay following total joint arthroplasty. Orthopedics 2009;32:167.
44. Post ZD, Restrepo C, Kahl LK, van de Leur T, Purtill JJ, Hozack WJ. A prospective evaluation of 2 dif erent pain management protocols for total hip arthroplasty. J Arthroplasty 2010;25:410-5.
45. Macfarlane RJ, Ng BH, Gamie Z, El Masry MA, Velonis S, Schizas C et al. Pharmacological treatment of heterotopic ossifcation following hip and acetabular surgery. Expert Opin Pharmacother 2008;9:767-86.
46. Meunier A, Lisander B, Good L. Efects of celecoxib on blood loss, pain, and recovery of function after total knee replacement: a randomized placebo-controlled trial. Acta Orthop 2007;78:661-7.
47. Huang YM, Wang CM, Wang CT, Lin WP, Horng LC, Jiang CC. Perioperative celecoxib administration for pain management after total knee arthroplasty - a randomized, controlled study. BMC Musculoskelet Disord 2008;9:77.
48. Dahners LE, Mullis BH. Efects of nonsteroidal anti-infammatory drugs on bone formation and soft-tissue healing. J Am Acad Orthop Surg 2004;12:139-43.
49. Cohen DB, Kawamura S, Ehteshami JR, Rodeo SA. In-domethacin and celecoxib impair rotator cuf tendon-to-bone healing. Am J Sports Med 2006;34:362-9.
50. Tan V, Nourbakhsh A, Capo J, Cottrell JA, Meyenhofer M, O'Connor JP. Efects of nonsteroidal anti-infammatory drugs on fexor tendon adhesion. J Hand Surg Am 2010;35:941-7.
51. Elia N, Lysakowski C, Tramèr MR. Does multimodal analgesia with acetaminophen, nonsteroidal antiinfammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine ofer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology 2005;103:1296-304.
52. McDaid C, Maund E, Rice S, Wright K, Jenkins B, Woola-cott N. Paracetamol and selective and non-selective nonsteroidal anti-infammatory drugs (NSAIDs) for the reduction of morphine-related side efects after major surgery: a systematic review. Health Technol Assess 2010;14:1-153.
53. Maund E, McDaid C, Rice S, Wright K, Jenkins B, Woola-cott N. Paracetamol and selective and non-selective nonsteroidal anti-infammatory drugs for the reduction in morphine-related side-efects after major surgery: a systematic review. Br J Anaesth 2011 [Epub ahead of print].
54. Acharya M, Dunning J. Does the use of non-steroidal anti-infammatory drugs after cardiac surgery increase the risk of renal failure? Interact Cardiovasc Torac Surg 2010;11:461-7.
55. Wattchow DA, De Fontgalland D, Bampton PA, Leach PL, McLaughlin K, Costa M. Clinical trial: the impact of cyclooxygenase inhibitors on gastrointestinal recovery after major surgery - a randomized double blind controlled trial of celecoxib or diclofenac vs. placebo. Aliment Pharmacol Ter 2009;30:987-98.
56. Lassen K, Soop M, Nygren J, Cox PB, Hendry PO, Spies C et al; Enhanced Recovery After Surgery (ERAS) Group. Consensus review of optimal perioperative care in colorectal surgery: Enhanced Recovery After Surgery (ERAS) Group recommendations. Arch Surg 2009;144:961-9.
57. Gimbel JS, Brugger A, Zhao W, Verburg KM, Geis GS. Efcacy and tolerability of celecoxib versus hydrocodone/ acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults. Clin Ter 2001;23:228-41.
58. Recart A, Issioui T, White PF, Klein K, Watcha MF, Stool L et al. Te efcacy of celecoxib premedication on postoperative pain and recovery times after ambulatory surgery: a dose-ranging study. Anesth Analg 2003;96:1631-5.
59. Sun T, Sacan O, White PF, Coleman J, Rohrich RJ, Kenkel JM. Perioperative versus postoperative celecoxib on patient outcomes after major plastic surgery procedures. Anesth Analg 2008;106:950-8.
60. Assareh H, Jacobson E, Doolke A, Jakobsson JG, Anderson RE. Is administration time of oral non-steroid antiinfammatory drugs important? A clinical study in patients undergoing arthroscopic subacromial decompression. Eur J Anaesthesiol 2007;24:467-9.
61. White PF, Sacan O, Tufanogullari B, Eng M, Nuangcham-nong N, Ogunnaike B. Efect of short-term postoperative celecoxib administration on patient outcome after outpatient laparoscopic surgery. Can J Anaesth 2007;54:342-8.
62. Sandhu T, Paiboonworachat S, Ko-lam W. Efects of preemptive analgesia in laparoscopic cholecystectomy: a double-blind randomized controlled trial. Surg Endosc 2011;25:23-7.
63. Brattwall M, Turan I, Jakobsson J. Pain management after elective hallux valgus surgery: a prospective randomized double-blind study comparing etoricoxib and tramadol. Anesth Analg 2010;111:544-9.
64. Ong CK, Seymour RA, Lirk P, Merry AF. Combining paracetamol (acetaminophen) with nonsteroidal antiinfammatory drugs: a qualitative systematic review of analgesic efcacy for acute postoperative pain. Anesth Analg 2010;110:1170-9.
65. Prospect - Procedure specifc postoperative pain management [Internet]. [cited May 4, 2011]. Available at: http:// www.postoppain.org/frameset.htm
66. Holte K, Andersen J, Jakobsen DH, Kehlet H. Cyclo-oxy-genase 2 inhibitors and the risk of anastomotic leakage after fast-track colonic surgery. Br J Surg 2009;96:650-4.
67. Klein M, Andersen LP, Harvald T, Rosenberg J, Gogenur I. Increased risk of anastomotic leakage with diclofenac treatment after laparoscopic colorectal surgery. Dig Surg 2009;26:27-30.
68. Desjardins PJ, Black PM, Daniels S, Bird SR, Fitzgerald BJ, Petruschke RA et al. A randomized controlled study comparing rofecoxib, diclofenac sodium, and placebo in post-bunionectomy pain. Curr Med Res Opin 2004;20:1523-37.
69. Chang DJ, Desjardins PJ, Chen E, Polis AB, McAvoy M, Mockoviak SH et al. Comparison of the analgesic efcacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: a randomized, placebo-controlled clinical trial. Clin Ter 2002;24:490-503.
70. White PF, Tang J, Wender RH, Zhao M, Time M, Zaentz A et al. The effects of oral ibuprofen and celecoxib in preventing pain, improving recovery outcomes and patient satisfaction after ambulatory surgery. Anesth Analg 2011;112:323-9.
71. Daniels SE, Bandy DP, Christensen SE, Boice J, Losada MC, Liu H et al. Evaluation of the dose range of etoricoxib in an acute pain setting using the postoperative dental pain model. Clin J Pain 2011;27:1-8.
72. Boonriong T, Tangtrakulwanich B, Glabglay P, Nimmaan-rat S. Comparing etoricoxib and celecoxib for preemptive analgesia for acute postoperative pain in patients undergoing arthroscopic anterior cruciate ligament reconstruction: A randomized controlled trial. BMC Musculoskelet Disord 2010;11:246.
73. Stefens JP, Santos FA, Pilatti GL. The use of etoricoxib and celecoxib for pain prevention after periodontal surgery: a double-masked, parallel-group, placebo-controlled randomized clinical trial. J Periodontol 2011 [Epub ahead of print].
74. Jones P, Lamdin R. Oral cyclo-oxygenase 2 inhibitors versus other oral analgesics for acute soft tissue injury: systematic review and meta-analysis. Clin Drug Investig 2010;3 0:419-37.
75. Nikanne E, Kokki H, Salo J, Linna TJ. Celecoxib and ketoprofen for pain management during tonsillectomy: a placebo-controlled clinical trial. Otolaryngol Head Neck Surg 2005;132:287-94.
76. Viola M, Quaratino D, Gaeta F, Caruso C, Valluzzi R, Romano A. Etoricoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inf ammatory drugs. Int Arch Allergy Immunol 2007;143:103-8.
77. Koschel D, Cardoso C, Leucht V, Hofken G. Asthmatic reaction induced by Etoricoxib in a patient with aspirin-sensitive asthma. Allergy 2008;63:1093-4.
78. Pagani M, Bonadonna P, Dama A, Senna GE, Vescovi PP, Antico A. Long-term tolerability of etoricoxib in diferent types of NSAID-intolerant subjects. Eur Ann Allergy Clin Immunol 2010;42:216-20.
79. [No authors listed]. Parecoxib and fatal skin reactions: when will this drug be withdrawn from the European Union market? Prescrire Int 2010;19:203.
80. La Grenade L, Lee L, Weaver J, Bonnel R, Karwoski C, Governale L et al. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COx-2 inhibitors. Drug Saf 2005;28:917-24.
81. Atzori L, Pinna AL, Pau M, Aste N, Zucca M, Ferreli C. Adverse cutaneous reactions to selective cyclooxygenase 2 inhibitors: experience of an Italian drug-surveillance center. J Cutan Med Surg 2006;10:31-5.
82. Eriksson H, Tenhunen A, Korttila K. Balanced analgesia improves recovery and outcome after outpatient tubal ligation. Acta Anaesthesiol Scand 1996;40:151-5.
83. Michaloliakou C, Chung F, Sharma S. Preoperative multimodal analgesia facilitates recovery after ambulatory laparoscopic cholecystectomy. Anesth Analg 1996;82:44-51.
84. Ghosh N, Chaki R, Mandal V, Mandal SC. COx-2 as a target for cancer chemotherapy. Pharmacol Rep 2010;62:233-44.
85. Perrone MG, Scilimati A, Simone L, Vitale P. Selective COx-1 inhibition: A therapeutic target to be reconsidered. Curr Med Chem 2010;17:3769-805.